|
2011 Journal Article A snapshot of research activities at the WA PET serviceFrancis, Roslyn, Segard, Tatiana, Maton, Penny and Campbell, Elaine (2011). A snapshot of research activities at the WA PET service. Gamma Gazette, 1 (4), 24-25. |
|
2011 Journal Article Multimodality imaging review of malignant pleural mesothelioma diagnosis and stagingGerbaudo, Victor H., Katz, Sharyn I., Nowak, Anna K. and Francis, Roslyn J. (2011). Multimodality imaging review of malignant pleural mesothelioma diagnosis and staging. PET Clinics, 6 (3), 275-297. doi: 10.1016/j.cpet.2011.04.001 |
|
2011 Journal Article A multimodality imaging review of malignant pleural mesothelioma response assessmentNowak, Anna K., Francis, Roslyn J., Katz, Sharyn I. and Gerbaudo, Victor H. (2011). A multimodality imaging review of malignant pleural mesothelioma response assessment. PET Clinics, 6 (3), 299-311. doi: 10.1016/j.cpet.2011.04.002 |
|
2011 Conference Publication CHARACTERISATION AND PROGNOSTIC SIGNIFICANCE OF GLOBAL AND REGIONAL HYPOXIA IN MESOTHELIOMA USING 18F-MISO PET/CT IMAGINGSegard, Tatiana M. L., Nowak, Anna K., Lee, Y. C. Gary, Millward, Michael, Morandeau, Laurence M. J. A., Campbell, Elaine M. and Francis, Roslyn J. (2011). CHARACTERISATION AND PROGNOSTIC SIGNIFICANCE OF GLOBAL AND REGIONAL HYPOXIA IN MESOTHELIOMA USING 18F-MISO PET/CT IMAGING. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2011 Conference Publication FINAL RESULTS OF A PHASE II STUDY OF SUNITINIB AS SECOND LINE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM)Nowak, A. K., Francis, R. J., Millward, M. J., van der Schaaf, A., Seguard, T., Creaney, J., Hasani, A., Musk, A. W. and Byrne, M. J. (2011). FINAL RESULTS OF A PHASE II STUDY OF SUNITINIB AS SECOND LINE THERAPY OF MALIGNANT PLEURAL MESOTHELIOMA (MPM). 3rd Australian Lung Cancer Conference (ALCC), Melbourne Australia, Oct 07-09, 2010. NEW YORK: ELSEVIER SCIENCE INC. |
|
2011 Journal Article Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burdenCreaney, Jenette, Francis, Roslyn J., Dick, Ian M., Musk, Arthur W., Robinson, Bruce W. S., Byrne, Michael J. and Nowak, Anna K. (2011). Serum soluble mesothelin concentrations in malignant pleural mesothelioma: Relationship to tumor volume, clinical stage and changes in tumor burden. Clinical Cancer Research, 17 (5), 1181-1189. doi: 10.1158/1078-0432.CCR-10-1929 |
|
2010 Journal Article Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest GroupNowak, Anna K., Armato, Samuel G., Ceresoli, Giovanni Luca, Yildirim, Huseyin and Francis, Roslyn J. (2010). Imaging in pleural mesothelioma: A review of Imaging Research Presented at the 9th International Meeting of the International Mesothelioma Interest Group. Lung Cancer, 70 (1), 1-6. doi: 10.1016/j.lungcan.2010.05.016 |
|
2010 Journal Article A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parametersNowak, Anna K., Francis, Roslyn J., Phillips, Michael J., Millward, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan, Musk, Arthur W., McCoy, Melanie J., Segal, Amanda, Robins, Peter, Byrne, Michael J. and Jolghazi, Anna (2010). A novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging with clinical parameters. Clinical Cancer Research, 16 (8), 2409-2417. doi: 10.1158/1078-0432.CCR-09-2313 |
|
2009 Journal Article A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphomaDancey, Gairin, Violet, John, Malaroda, Alessandra, Green, Alan J., Sharma, Surinder K., Francis, Roslyn, Othman, Shokri, Parker, Sweta, Buscombe, John, Griffin, Natalie, Chan, Pei-San, Malhotra, Anmol, Woodward, Nicholas, Ramsay, Alan, Ross, Philip, Lister, T. Andrew, Amlot, Peter, Begent, Richard and McNamara, Christopher (2009). A phase I clinical trial of CHT-25 a 131I-labeled chimeric anti-CD25 antibody showing efficacy in patients with refractory lymphoma. Clinical Cancer Research, 15 (24), 7701-7710. doi: 10.1158/1078-0432.CCR-09-1421 |
|
2008 Journal Article Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom studyBoucek, J. A., Francis, R. J., Jones, C. G., Khan, N., Turlach, B. A. and Green, A. J. (2008). Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax - A phantom study. Physics in Medicine and Biology, 53 (16), 4213-4230. doi: 10.1088/0031-9155/53/16/001 |
|
2008 Journal Article Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary resultsGreen, A. J., Francis, R. J., Baig, S. and Begent, R. H.J. (2008). Semiautomatic volume of interest drawing for 18F-FDG image analysis - Method and preliminary results. European Journal of Nuclear Medicine and Molecular Imaging, 35 (2), 393-406. doi: 10.1007/s00259-007-0602-3 |
|
2007 Journal Article Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scansFrancis, Roslyn J., Byrne, Michael J., Van Der Schaaf, Agatha A., Boucek, Jan A., Nowak, Anna K., Phillips, Michael, Price, Richard, Patrikeos, Andrew P., Musk, A. William and Millward, Michael J. (2007). Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans. Journal of Nuclear Medicine, 48 (9), 1449-1458. doi: 10.2967/jnumed.107.042333 |
|
2006 Journal Article A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrugMayer, Astrid, Francis, Roslyn J., Sharma, Surinder K., Tolner, Berend, Springer, Caroline J., Martin, Jan, Boxer, Geoff M., Bell, James, Green, Alan J., Hartley, John A., Cruickshank, Clare, Wren, Julie, Chester, Kerry A. and Begent, Richard H. J. (2006). A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. Clinical Cancer Research, 12 (21), 6509-6516. doi: 10.1158/1078-0432.CCR-06-0769 |
